Main Article Content
Introduction: To describe the multiplicity of ocular manifestations of COVID-19 patients, we report a case of bilateral conjunctivitis related with SARS-CoV-2 infection without respiratory involvement in a patient with novel coronavirus disease (COVID-19).
Case Summary: A 25-year-old healthy female developed severe conjunctivitis in her right eye, followed by her left eye 4 days after fever and myalgia. The patient had no symptoms of cough, shortness of breath. On day 7, nasopharyngeal swab to identify SARS-CoV-2 by RT-PCR was positive and on day 10, after worsening of conjunctivitis, conjunctival swab specimens were found positive for SARS-CoV-2. There were no respiratory symptoms, her chest x ray and chest computed tomography (CT) did not show pneumonia.
Discussion and Conclusion: SARS-CoV-2 can cause life-threatening respiratory failure, but there are evidences representing alternative modes of transmission and others organs complications that can be also life threatening. In this case we describe a severe bilateral viral conjunctivitis in a young woman with COVID-19 infection and on day 10 after severe symptoms, conjunctival swab RT-PCR test result was positive. There are few studies that shows, presence of coronavirus in tears and conjunctival secretions is probably due to direct inoculation of SARS-CoV-2 from infected droplets, the migration by the nasolacrimal duct, or hematogenous infection of the lacrimal gland. Few studies with a positive RT-PCR test findings in conjunctival swab samples of confirmed COVID-19 patients provide objective evidence for SARS-CoV-2 ocular surface infection. However, some patients with positive conjunctival RT-PCR results with no evidence of conjunctivitis.
Accessed 30 July 2020.
Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020;94(7):e00127-20
Hunt M, Koziatek C. A case of COVID-19 pneumonia in a young male with full body rash as a presenting symptom. Clin Pract Cases Emerg Med. 2020;4(2):219–21.
Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020;138(5):575–578.
Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol; 2020.
Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395.
Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalized patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–751.
Loffredo L, Pacella F, Pacella E, et al. Conjunctivitis and COVID-19: A meta-analysis. J Med Virol. 2020;92(9):1413–1414.
Navel V, Chiambaretta F, Dutheil F. Hemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep. 2020;19: 100735.
Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;S0008-4182(20):30305-7.
Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol; 2020.
DOI: 10.1002/ jmv.25725
Qiao C, Zhang H, He M, et al. Symptomatic COVID-19 in Eye Professionals in Wuhan, China [published online ahead of print, 2020 Apr 18]. Ophthalmology. 2020;S0161-6420(20):30403-6.